By analyzing immune cell infiltration in the tumor microenvironment and prognosis, we found that the 5-year OS rate in the group with high CD4+T cell infiltration was lower than that in the group with low CD4+T cell infiltration (Figure 3(a)) and was 9.1% and 60.4%, respectively. The gene discussed is CD4; the disease is neoplasm.